Abstract: An aqueous inkjet ink is disclosed that contains a water-dispersible polyether-type aliphatic urethane-based resin (A), a water-dispersible (meth)acrylic-based resin (B), a surfactant containing an acetylene glycol-based surfactant (C) having an HLB value of not more than 10.0, a colorant, and water. An ink set is also disclosed.

Abstract: An oil-based magnetic ink having an improved long-term storage stability is provided. The oil-based magnetic ink contains ferrite particles, a dispersant, a petroleum-based hydrocarbon solvent, a fatty acid ester-based solvent, and at least one selected from the group consisting of a glycol ether-based solvent and an alkanediol-based solvent, wherein the glycol ether-based solvent is a compound represented by R1O—(R2O)m—H where R1 is an alkyl group having 4 to 8 carbon atoms, R2 is an alkylene group having 2 or 3 carbon atoms, and m is 3 or 4, and the alkanediol-based solvent is an alkanediol-based solvent having 6 to 10 carbon atoms.

Abstract: An ink for inkjet printing including a pigment, a water-dispersible resin, water, and a water-soluble organic solvent, wherein the water-dispersible resin is an anionic resin having a film elongation of 400-1,000%, a tensile strength of 20 to 50 N/mm2 and an absolute value for the zeta potential (mV) of 40 or greater, the amount of the anionic resin, reported as a weight ratio relative to the pigment, is within a range from (0.5 to 2.5)/1, and the surface tension of the ink is within a range from 30 to 50 mN/m.

Abstract: An active energy beam-curable ink, comprising a polytetramethylene glycol diacrylate, a bifunctional to tetrafunctional urethane acrylate and a colorant, wherein an amount of the polytetramethylene glycol diacrylate relative to a total mass of the ink is not less than 35% by mass, and an amount of the bifunctional to tetrafunctional urethane acrylate relative to a total mass of the ink is within a range from 5 to 35% by mass.

Abstract: An ink for inkjet textile printing comprising a pigment, a water-dispersible resin, water, and a water-soluble organic solvent, wherein the water-soluble organic solvent comprises a polyol having an SP value within a range from 10 to 15.5 (cal/cm3)1/2, and the water-dispersible resin comprises a urethane resin having a glass transition point within a range from ?35 to 10° C.

Abstract: An ink for inkjet printing comprising a pigment, a water-dispersible resin, water, and a water-soluble organic solvent, wherein the water-dispersible resin is an anionic resin having a film elongation of 400-1,000%, a tensile strength of 20 to 50 N/mm2 and an absolute value for the zeta potential (mV) of 40 or greater, the amount of the anionic resin, reported as a weight ratio relative to the pigment, is within a range from (0.5 to 2.5)/1, and the surface tension of the ink is within a range from 30 to 50 mN/m.

Abstract: An ink for inkjet recording containing a vehicle, coloring agents dispersed therein, and a dispersing agent for the coloring agents as required, is provided. The vehicle contains at least a first solvent component and a second solvent component. The first solvent component has the lowest boiling point among the components in the ink, and has a higher viscosity than the ink. The second solvent component has a higher boiling point than the first one. The boiling point of the first solvent component is preferably 280 degree C. or below, and the content thereof is preferably 10 to 80% by weight based on the total weight of the ink. Even when the ink is printed on non-coated papers, the vehicle penetrates little in the thickness direction and bleeds little in the horizontal direction. Clogging in the nozzles can be prevented effectively using the ink even when it has been left in an open atmosphere for a long time.

Abstract: An ink for inkjet recording containing a vehicle, coloring agents dispersed therein, and a dispersing agent for the coloring agents as required, is provided. The vehicle contains at least a first solvent component and a second solvent component. The first solvent component has the lowest boiling point among the components in the ink, and has a higher viscosity than the ink. The second solvent component has a higher boiling point than the first one. The boiling point of the first solvent component is preferably 280 degree C. or below, and the content thereof is preferably 10 to 80% by weight based on the total weight of the ink. Even when the ink is printed on non-coated papers, the vehicle penetrates little in the thickness direction and bleeds little in the horizontal direction. Clogging in the nozzles can be prevented effectively using the ink even when it has been left in an open atmosphere for a long time.

Abstract: A triazolo-1,4-di-azepine compound of the below given formula and a pharmacologically acceptable salt thereof are useful in the pharmaceutical field, especially in treating allergic diseases. ##STR1## in which R.sup.1 and R.sup.2 are hydrogen or an alkyl, R.sup.3 is hydrogen or a halogen, R.sup.4 is hydrogen or an alkyl, X is --OCO--, and Y is a cycloalkyl, a cycloalkylalkyl, an alkynyl or others.

Abstract: A triazolo-1,4-di-azepine compound of the below given formula and a pharmacologically acceptable salt thereof are disclosed and useful in the pharmaceutical field, especially to allergic diseases. ##STR1## in which R.sup.1 and R.sup.2 are hydrogen or an alkyl, R.sup.3 is hydrogen or a halogen, R.sup.4 is hydrogen or an alkyl, X is --OCO--, --NHCO--, --CO-- or others and Y is a cycloalkyl, a cycloalkylalkyl, an alkynyl or others.

Abstract: A triazolo-1,4-di-azepine compound of the below given formula and a pharmacologically acceptable salt thereof are disclosed and useful in the pharmaceutical field, especially to allergic diseases. ##STR1## in which R1 and R2 are hydrogen or an alkyl, R3 is hydrogen or a halogen, R4 is hydrogen or an alkyl, X is --OOO--, --NHCO--, --CO-- or others and Y is a cycloalkyl, a cycloalkylalkyl, an alkynyl or others.

Abstract: A triazolo-1,4-di-azepine compound of the below given formula and a pharmacologically acceptable salt thereof are disclosed and useful in the pharmaceutical field, especially to treat allergic diseases: ##STR1## in which R1 and R2 are hydrogen or an alkyl, R3 is hydrogen or a halogen, R4 is hydrogen or an alkyl, X is --OCO--, --NHCO--, --CO-- or others and Y is a cycloalkyl, a cycloalkylalkyl, an alkynyl or others.

Abstract: A triazolo-1,4-azepine compound of the below given formulas and a pharmacologically acceptable salt thereof are disclosed and useful in the pharmaceutical field, especially to allergic diseases. ##STR1## in which R1 and R2 are hydrogen or an alkyl, R3 is hydrogen or a halogen, R4 is hydrogen or an alkyl, X is --OCO--, --NHCO--, --CO-- or others and Y is a cycloalkyl, a cycloalkylalkyl, an alkynyl or others.

Abstract: A triazolo-1,4-di-azepine compound of the below given formula and a pharmacologically acceptable salt thereof are disclosed and useful in the pharmaceutical field, especially to allergic diseases, ##STR1## in which R.sup.1 and R.sup.2 are hydrogen or an alkyl, R.sup.3 is hydrogen or a halogen, R.sup.4 is hydrogen or an alkyl, X is --OCO--, --NHCO--, --CO-- or others and Y is a cycloalkyl, a cycloalkylalkyl, an alkynyl or others.

Abstract: A triazolo-1,4-di-azepine compound of the below given formulas and a pharmacologically acceptable salt thereof are disclosed and useful in the pharmaceutical field, especially to allergic diseases. ##STR1## in which R1 and R2 are hydrogen or an alkyl, R3 is hydrogen or a halogen, R4 is hydrogen or an alkyl, X is --OCO--, --NHCO--, --CO-- or others and Y is a cycloalkyl, a cycloalkylalkyl, an alkynyl or others.

Abstract: Dolichol or phosphate thereof is useful as a therapeutically treating and preventive agent, in particular, for hyperuricuria, hyperlipemia, diabetes and hepatic diseases.

Abstract: Dolichol or phosphate thereof is useful as a therapeutically treating and preventive agent, in particular, for hyperuricuria, hyperlipemia, diabetes and hepatic diseases.

Abstract: Dolichol or phosphate thereof is useful as a therapeutically treating and preventive agent, in particular, for hyperuricuria, hyperlipemia, diabetes and hepatic diseases.

Abstract: Dolichol or phosphate thereof is useful as a therapeutically treating and preventive agent, in particular, for hyperuricuria, hyperlipemia, diabetes and hepatic diseases.